[
  {
    "date": "2023-12-31",
    "symbol": "NCNA",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "NCNA",
    "entityregistrantname": "NUCANA PLC",
    "entitycentralindexkey": 1709626,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitycommonstocksharesoutstanding": 52860335,
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "American Depositary Shares, each representing one Ordinary Share, nominal value £0.04 per share",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-38215",
    "entityincorporationstatecountrycode": "X0",
    "contactpersonnelname": "Hugh S. Griffith",
    "entityaddressaddressline1": "NuCana plc",
    "entityaddressaddressline2": "3 Lochside Way",
    "entityaddresscityortown": "Edinburgh",
    "entityaddresscountry": "GB",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "localphonenumber": "357 1111",
    "cityareacode": 131,
    "entityaddresspostalzipcode": "EH12 9DT",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "documentregistrationstatement": "false",
    "documentshellcompanyreport": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 1438,
    "auditorlocation": "Edinburgh, United Kingdom",
    "researchanddevelopmentexpense": 25062000,
    "administrativeexpense": 6063000,
    "impairmentlossrecognisedinprofitorloss": 503000,
    "gainslossesonexchangedifferencesontranslationbeforetax": -1156000,
    "profitlossfromoperatingactivities": -32784000,
    "financeincome": 754000,
    "profitlossbeforetax": -32030000,
    "incometaxexpensecontinuingoperations": -4398000,
    "profitloss": -27632000,
    "basicearningslosspershare": -0.53,
    "dilutedearningslosspershare": -0.53,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -41000,
    "othercomprehensiveincome": -41000,
    "comprehensiveincome": -27673000,
    "comprehensiveincomeattributabletoownersofparent": -27673000,
    "intangibleassetsotherthangoodwill": 2128000,
    "propertyplantandequipment": 521000,
    "deferredtaxassets": 143000,
    "noncurrentassets": 2792000,
    "tradeandothercurrentreceivables": 2671000,
    "currenttaxassetscurrent": 5123000,
    "cashandcashequivalents": 17225000,
    "currentassets": 25019000,
    "assets": 27811000,
    "sharecapitalandsharepremium": 143420000,
    "otherreserves": 79173000,
    "retainedearnings": -207706000,
    "equity": 14887000,
    "noncurrentprovisions": 58000,
    "noncurrentleaseliabilities": 190000,
    "noncurrentliabilities": 248000,
    "tradeandothercurrentpayablestotradesuppliers": 3375000,
    "currentprovisionsforemployeebenefits": 155000,
    "accrualsclassifiedascurrent": 8940000,
    "currentleaseliabilities": 206000,
    "currentliabilities": 12676000,
    "liabilities": 12924000,
    "equityandliabilities": 27811000,
    "increasedecreasethroughsharebasedpaymenttransactions": 3857000,
    "increasedecreasethroughexerciseofoptions": 3000,
    "lapseofshareoptions": -238000,
    "issueofequity": 16000,
    "shareissuerelatedcost": 36000,
    "adjustmentsforincometaxexpense": -4398000,
    "adjustmentsfordepreciationandamortisationexpense": 575000,
    "adjustmentsforimpairmentofintangibleassets": 503000,
    "adjustmentsforprovisions": -4109000,
    "adjustmentsforfinanceincome": 754000,
    "interestexpenseonleaseliabilities": 29000,
    "adjustmentsforsharebasedpayments": 3857000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 1176000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -30753000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 1234000,
    "adjustmentsforincreasedecreaseintradeaccountpayable": -1428000,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": -1087000,
    "increasedecreaseinworkingcapital": 1281000,
    "cashflowsfromusedinoperations": -32034000,
    "incometaxespaidrefundclassifiedasoperatingactivities": -5595000,
    "cashflowsfromusedinoperatingactivities": -26439000,
    "interestreceivedclassifiedasinvestingactivities": 770000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 4000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 474000,
    "purchaseofotherassetsclassifiedasinvestingactivities": -2596000,
    "cashflowsfromusedininvestingactivities": 2888000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 270000,
    "proceedsfromexerciseofoptions": 4000,
    "proceedsfromissuingshares": 249000,
    "paymentsforshareissuecosts": 36000,
    "cashflowsfromusedinfinancingactivities": -53000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -23604000,
    "effectofexchangeratechangesoncashandcashequivalents": -1083000,
    "nameofreportingentityorothermeansofidentification": "NuCana plc",
    "descriptionofnatureofentitysoperationsandprincipalactivities": "clinical-stage biopharmaceutical company developing a portfolio of new medicines to treat patients with cancer",
    "domicileofentity": "United Kingdom",
    "countryofincorporation": "England and Wales",
    "nameofsubsidiary": "NuCana Limited, NuCana, Inc. and NuCana BioMed Trustee Company Limited",
    "numberofsubsidiaries": 3,
    "accruedclinicaltrialexpenses": 6200000,
    "accruedinvestigatorfeesexpense": 4800000,
    "prepaymentsforclinicaltrialexpenses": 1000000,
    "accruedcontractedmanufacturingexpense": 400000,
    "prepaymentsforcontractedmanufacturingexpense": 41000,
    "numberofoperatingsegment": 1,
    "usefullivesoramortizationratesofintangibleassetsotherthangoodwill": "P20Y",
    "cashatbanksmaturityperiod": "three months or less",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P2Y",
    "depreciationmethodpropertyplantandequipment": "Straight-line",
    "amortisationmethodintangibleassetsotherthangoodwill": "Straight-line",
    "wagesandsalaries": 4530000,
    "socialsecuritycontributions": 516000,
    "postemploymentbenefitexpensedefinedbenefitplans": 210000,
    "expensefromsharebasedpaymenttransactionswithemployees": 2551000,
    "employeebenefitsexpense": 7807000,
    "averagenumberofemployees": 23,
    "directorsremunerationexpense": 1216000,
    "directorsremunerationpensionandotherbenefitsexpense": 61000,
    "directorsremunerationexpenseincludingpensionandotherbenefitsexpense": 1277000,
    "numberofdirectorsexercisedshareoptions": 2,
    "gainonexerciseofoption": 8000,
    "weightedaverageshares": 52573000,
    "amortisationexpense": 208000,
    "depreciationexpense": 367000,
    "milestonepayments": 1875000,
    "estimatedfinancialeffectofcontingentliabilities": 100000,
    "currentlyprevailingpercentageofemployernationalinsurance": 0.138,
    "currenttaxexpenseincome": -4558000,
    "adjustmentsforcurrenttaxofpriorperiod": 206000,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": -4351000,
    "deferredtaxexpenseincome": -48000,
    "adjustmentsfordeferredtaxofpriorperiods": 1000,
    "deferredtaxexpenseincomerecognisedinprofitorloss": -47000,
    "accountingprofit": -32030000,
    "taxexpenseincomeatapplicabletaxrate": -7533000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 4818000,
    "taxeffectofdeductionforresearchanddevelopment": -7394000,
    "taxeffectoftaxlosses": 7394000,
    "taxeffectofdeferredtaxprioryearadjustment": 1000,
    "taxeffectofforeigntaxratescurrentyear": 1000,
    "taxeffectofresearchanddevelopmenttaxcreditforeign": -48000,
    "taxeffectofresearchanddevelopmenttaxcreditcurrentyear": -4558000,
    "taxeffectofresearchanddevelopmenttaxcreditprioryears": 206000,
    "applicabletaxrate": 0.2352,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 99100000,
    "temporarydifferencesforsharebasedcompensationarrangements": 600000,
    "cumulativecarryforwardtaxlosses": 98500000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 474000,
    "amortisationintangibleassetsotherthangoodwill": 208000,
    "impairmentlossrecognisedinprofitorlossintangibleassetsotherthangoodwill": 503000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 4000,
    "revaluationincreasedecreasepropertyplantandequipment": 4000,
    "depreciationpropertyplantandequipment": 212000,
    "disposalspropertyplantandequipment": 10000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": -22000,
    "securitydeposittocoverlegalcosts": 3000000,
    "prepaymentsmanufacturingandclinical": 1081000,
    "prepaymentsother": 888000,
    "accruedincomeotherthancontractassets": 21000,
    "valueaddedtaxreceivables": 663000,
    "otherreceivables": 18000,
    "tradeandotherreceivables": 2671000,
    "issuedcapital": 2114000,
    "sharepremium": 141306000,
    "numberofsharesissued": 52860000,
    "parvaluepershare": 0.04,
    "numberofsharesissuedandfullypaid": 52860000,
    "numberofsharesissuedonexerciseofoptions": 79000,
    "increasedecreaseinnumberofordinarysharesissued": 408000,
    "issueofsharecapital": 16000,
    "ownsharereserve": -339000,
    "reserveofexchangedifferencesontranslation": 3000,
    "capitalreserve": 42466000,
    "shareoptionreserve": 37043000,
    "reserveofsharebasedpayment": 3907000,
    "reserveofshareoptionsexercised": -277000,
    "reserveofshareoptionsforfeiture": -50000,
    "lapseofshareoptionsreserve": -238000,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 500000,
    "numberofequitysettledsharebasedpaymentplans": 6,
    "descriptionofoptionlifeshareoptionsgranted": 10,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P6Y7M28D",
    "termofshareoptionsexercised": "P2Y",
    "numberofoutstandingshareoptions": 14001224,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 2733139,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 97180,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 253454,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 102957,
    "numberofshareoptionsvestedandexercisableinsharebasedpaymentarrangement": 7564156,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 2.59,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 0.82,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 1.37,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 1.42,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.04,
    "weightedaverageexercisepriceofshareoptionsvestedandexercisableinsharebasedpaymentarrangement": 3.61,
    "weightedaverageexercisepriceofshareoptionsinsharebasedpaymentarrangementexercisedduringperiodatdateofexercise2019": 0.68,
    "exercisepriceofoutstandingshareoptions2019": 0.04,
    "descriptionofvestingdateofshareoptionsgranted": "2024-01-11",
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.9711,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0331,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 870,
    "weightedaveragesharepriceshareoptionsgranted2019": 1.23,
    "exercisepriceshareoptionsgranted2019": 1.23,
    "descriptionoflapsedateofshareoptionsgranted": "2033-01-11",
    "informationaboutnatureoflesseesleasingactivities": "lease terms of between two and five years",
    "cashoutflowforleases": 300000,
    "informationaboutlesseesexposurearisingfromvariableleasepayments": "The Company has one lease contract with variable payments where the lease costs after the first year of the lease are increased based upon a consumer price index and, therefore, the lease liability for this lease was re-measured at December 31, 2023.",
    "numberofleasecontractswithvariableleasepayments": 1,
    "informationaboutlesseesexposurearisingfromextensionoptionsandterminationoptions": "The Company has a number of lease contracts that include extension and termination options. These options are negotiated by management to provide flexibility in managing the leased asset portfolio and align it with the Company’s business needs. None of the termination options have been exercised or are expected to be exercised, however, two leases terminated on expiry in 2022.",
    "leaseliabilities": 396000,
    "expenserelatingtoleasesoflowvalueassetsforwhichrecognitionexemptionhasbeenused": 4000,
    "expenserelatingtoshorttermleasesforwhichrecognitionexemptionhasbeenused": 270000,
    "expenserelatingtovariableleasepaymentsnotincludedinmeasurementofleaseliabilities": 6000,
    "undiscountedoperatingleasepaymentstobereceived": 224000,
    "leaseeffectofdiscounting": -33000,
    "depreciationrightofuseassets": 212000,
    "gainslossesarisingfromsaleandleasebacktransactions": 241000,
    "undiscountedoperatingleasepaymentsextensionoptionsnotexpectedtobeexercised": 256000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 2684000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 145000,
    "keymanagementpersonnelcompensationsharebasedpayment": 3154000,
    "keymanagementpersonnelcompensation": 5983000,
    "increaseininterestrates": 0.005,
    "increaseininterestincomeoncashandcashequivalentsheldonvariableandshorttermfixedratedeposits": 45000,
    "percentageofincreaseinforeignexchangerate": 0.01,
    "increasedecreasethroughforeignexchangefinancialassetsliabilities": 74000,
    "prepaymentsandaccruedincomeandotherreceivables": 2027000,
    "tradeandotherpayablestotradesuppliers": 596000,
    "provision": 58000,
    "provisionsadditionsnewprovisions": 21000,
    "provisionsunusedprovisionreversed": -46000,
    "provisionsutilized": -3801000,
    "provisionstransferfromprepaymentsaccruedincomeandotherreceivables": -247000,
    "provisionsincreasedecreasethroughnetexchangedifferences": -6000,
    "provisions": 58000
  },
  {
    "date": "2022-12-31",
    "symbol": "NCNA",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "NCNA",
    "entityregistrantname": "NUCANA PLC",
    "entitycentralindexkey": 1709626,
    "currentfiscalyearenddate": "December 31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitycommonstocksharesoutstanding": "null",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "American Depositary Shares, each representing one Ordinary Share, nominal value £0.04 per share",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityfilenumber": "001-38215",
    "entityincorporationstatecountrycode": "England and Wales",
    "contactpersonnelname": "Hugh S. Griffith",
    "entityaddressaddressline1": "NuCana plc",
    "entityaddressaddressline2": "3 Lochside Way",
    "entityaddresscityortown": "Edinburgh",
    "entityaddresscountry": "United Kingdom",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "localphonenumber": "357 1111",
    "cityareacode": 131,
    "entityaddresspostalzipcode": "EH12 9DT",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "documentregistrationstatement": "false",
    "documentshellcompanyreport": "false",
    "icfrauditorattestationflag": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 1438,
    "auditorlocation": "Edinburgh, United Kingdom",
    "researchanddevelopmentexpense": 36426000,
    "administrativeexpense": 7291000,
    "impairmentlossrecognisedinprofitorloss": 292000,
    "gainslossesonexchangedifferencesontranslationbeforetax": 4887000,
    "profitlossfromoperatingactivities": -39122000,
    "financeincome": 669000,
    "profitlossbeforetax": -38453000,
    "incometaxexpensecontinuingoperations": -6432000,
    "profitloss": -32021000,
    "basicanddilutedearninglosspershare": -0.61,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 61000,
    "othercomprehensiveincome": 61000,
    "comprehensiveincome": -32021000,
    "comprehensiveincomeattributabletoownersofparent": -31960000,
    "intangibleassetsotherthangoodwill": 1000,
    "propertyplantandequipment": 183000,
    "deferredtaxassets": 103000,
    "noncurrentassets": 3334000,
    "tradeandothercurrentreceivables": 3957000,
    "currenttaxassetscurrent": 1000,
    "othercurrentassets": 2684000,
    "cashandcashequivalents": 27924000,
    "currentassets": 54920000,
    "assets": 58254000,
    "sharecapitalandsharepremium": 143203000,
    "otherreserves": 75872000,
    "retainedearnings": -180573000,
    "equity": -180573000,
    "noncurrentprovisions": 46000,
    "noncurrentleaseliabilities": 396000,
    "noncurrentliabilities": 442000,
    "tradeandothercurrentpayablestotradesuppliers": 4803000,
    "currentprovisionsforemployeebenefits": 162000,
    "accrualsclassifiedascurrent": 1694000,
    "currentleaseliabilities": 243000,
    "currentprovisions": 4100000,
    "currentliabilities": 19310000,
    "liabilities": 19752000,
    "equityandliabilities": 58254000,
    "increasedecreasethroughsharebasedpaymenttransactions": 4890000,
    "increasedecreasethroughexerciseofoptions": 24000,
    "lapseofshareoptions": 854000,
    "adjustmentsforincometaxexpense": -6432000,
    "adjustmentsfordepreciationandamortisationexpense": 732000,
    "adjustmentsforimpairmentofintangibleassets": 292000,
    "adjustmentsforprovisions": 4100000,
    "adjustmentsforfinanceincome": 669000,
    "interestexpenseonleaseliabilities": 21000,
    "adjustmentsforsharebasedpayments": 4890000,
    "adjustmentsforunrealisedforeignexchangelossesgains": -5014000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -34101000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 307000,
    "adjustmentsforincreasedecreaseintradeaccountpayable": 2974000,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": 442000,
    "increasedecreaseinworkingcapital": -3723000,
    "cashflowsfromusedinoperations": -30378000,
    "incometaxespaidrefundclassifiedasoperatingactivities": -7220000,
    "cashflowsfromusedinoperatingactivities": -23158000,
    "interestreceivedclassifiedasinvestingactivities": 638000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 12000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 506000,
    "cashflowsfromusedininvestingactivities": 120000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 227000,
    "proceedsfromexerciseofoptions": 66000,
    "cashflowsfromusedinfinancingactivities": -161000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -23199000,
    "effectofexchangeratechangesoncashandcashequivalents": 4847000,
    "nameofreportingentityorothermeansofidentification": "NuCana plc",
    "descriptionofnatureofentitysoperationsandprincipalactivities": "clinical-stage biopharmaceutical company developing a portfolio of new medicines to treat patients with cancer",
    "domicileofentity": "United Kingdom",
    "countryofincorporation": "England and Wales",
    "nameofsubsidiary": "NuCana Limited, NuCana, Inc. and NuCana BioMed Trustee Company Limited",
    "numberofsubsidiaries": 3,
    "accruedclinicaltrialexpenses": 6600000,
    "prepaymentsforclinicaltrialexpenses": 1800000,
    "accruedcontractedmanufacturingexpense": 400000,
    "prepaymentsforcontractedmanufacturingexpense": 100000,
    "numberofoperatingsegment": 1,
    "usefullivesoramortizationratesofintangibleassetsotherthangoodwill": "5 years",
    "cashatbanksmaturityperiod": " less than three months",
    "incometaxcreditcashrebatepercentage": 0.3335,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "five years",
    "legalproceedingsprovision": 4099999.9999999995,
    "depreciationmethodpropertyplantandequipment": "Straight-line",
    "amortisationmethodintangibleassetsotherthangoodwill": "Straight-line",
    "wagesandsalaries": 1587000,
    "socialsecuritycontributions": 155000,
    "postemploymentbenefitexpensedefinedbenefitplans": 46000,
    "expensefromsharebasedpaymenttransactionswithemployees": 4900000,
    "employeebenefitsexpense": 12353000,
    "averagenumberofemployees": 33,
    "directorsremunerationexpense": 966000,
    "directorsremunerationpensionandotherbenefitsexpense": 57000,
    "directorsremunerationexpenseincludingpensionandotherbenefitsexpense": 1023000,
    "numberofdirectorsexercisedshareoptions": 3,
    "gainonexerciseofoption": 48000000,
    "weightedaverageshares": 52235000,
    "amortisationexpense": 239000,
    "depreciationexpense": 473000,
    "researchcollaborationandlicenseagreementadditionalterm": "two years",
    "milestonepayments": 4500000,
    "estimatedfinancialeffectofcontingentliabilities": 100000,
    "currentlyprevailingpercentageofemployernationalinsurance": 0.138,
    "currenttaxexpenseincome": 3000,
    "adjustmentsforcurrenttaxofpriorperiod": -35000,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": -6398000,
    "deferredtaxexpenseincome": -34000,
    "adjustmentsfordeferredtaxofpriorperiods": 2711000,
    "deferredtaxexpenseincomerecognisedinprofitorloss": -34000,
    "accountingprofit": -38453000,
    "taxexpenseincomeatapplicabletaxrate": -7306000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 4595000,
    "taxeffectofdeductionforresearchanddevelopment": -8342000,
    "taxeffectoftaxlosses": 8342000,
    "taxeffectofforeigntaxratescurrentyear": 3000,
    "taxeffectofresearchanddevelopmenttaxcreditforeign": -34000,
    "taxeffectofresearchanddevelopmenttaxcreditcurrentyear": -6366000,
    "taxeffectofresearchanddevelopmenttaxcreditprioryears": -35000,
    "applicabletaxrate": 0.19,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 85900000,
    "temporarydifferencesforsharebasedcompensationarrangements": 1300000,
    "cumulativecarryforwardtaxlosses": 84600000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 506000,
    "amortisationintangibleassetsotherthangoodwill": 239000,
    "disposalsintangibleassetsotherthangoodwill": -214000,
    "impairmentlossrecognisedinprofitorlossintangibleassetsotherthangoodwill": 300000,
    "numberofclinicaltrial": 3,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 10000,
    "revaluationincreasedecreasepropertyplantandequipment": 483000,
    "depreciationpropertyplantandequipment": 473000,
    "disposalspropertyplantandequipment": -401000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": 23000,
    "otherassets": 2684000,
    "securitydeposittocoverlegalcosts": 3000000,
    "provisions": 3000000,
    "prepaymentsmanufacturingandclinical": 1890000,
    "prepaymentsother": 1416000,
    "accruedincomeotherthancontractassets": 36000,
    "valueaddedtaxreceivables": 601000,
    "otherreceivables": 14000,
    "tradeandotherreceivables": 3957000,
    "issuedcapital": 2095000,
    "sharepremium": 141108000,
    "numberofsharesissued": 52373000,
    "parvaluepershare": 0.04,
    "numberofsharesissuedandfullypaid": 52373000,
    "numberofsharesissuedonexerciseofoptions": 193000,
    "reserveofdiscretionaryparticipationfeatures": -339000,
    "reserveofexchangedifferencesontranslation": 44000,
    "capitalreserve": 42466000,
    "shareoptionreserve": 33701000,
    "reserveofsharebasedpayment": 5133000,
    "reserveofshareoptionsexercised": -362000,
    "reserveofshareoptionsforfeiture": -243000,
    "lapseofshareoptionsreserve": -854000,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 500000,
    "numberofequitysettledsharebasedpaymentplans": 6,
    "descriptionofoptionlifeshareoptionsgranted": 2.5,
    "shareoptionsgrantedvestingperiod": "four years",
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": 6.99,
    "termofshareoptionsexercised": 2,
    "numberofoutstandingshareoptions": "null",
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 105363,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 207833,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 151350,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 219220,
    "numberofshareoptionsvestedandexercisableinsharebasedpaymentarrangement": "null",
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 2.94,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 0.39,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 2.83,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 8.4,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.3,
    "weightedaverageexercisepriceofshareoptionsvestedandexercisableinsharebasedpaymentarrangement": 3.63,
    "weightedaverageexercisepriceofshareoptionsinsharebasedpaymentarrangementexercisedduringperiodatdateofexercise2019": 0.85,
    "exercisepriceofoutstandingshareoptions2019": 18.05,
    "descriptionofvestingdateofshareoptionsgranted": "Jul 12, 2026",
    "descriptionofexpectedvolatilityshareoptionsgranted": 1.0318,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0179,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 640,
    "weightedaveragesharepriceshareoptionsgranted2019": 0.67,
    "exercisepriceshareoptionsgranted2019": 0.04,
    "descriptionoflapsedateofshareoptionsgranted": "Jul 12, 2032",
    "informationaboutnatureoflesseesleasingactivities": "lease terms of between two and five years",
    "cashoutflowforleases": 200000,
    "informationaboutlesseesexposurearisingfromvariableleasepayments": "The Company has one lease contract with variable payments where the lease costs after the first year of the lease are increased based upon a consumer price index.",
    "numberofleasecontractswithvariableleasepayments": 1,
    "informationaboutlesseesexposurearisingfromextensionoptionsandterminationoptions": "The Company has a number of lease contracts that include extension and termination options. These options are negotiated by management to provide flexibility in managing the leased asset portfolio and align it with the Company’s business needs. None of the termination options have been exercised or are expected to be exercised, however, two leases terminated on expiry in 2022.",
    "numberofleasesterminated": 2,
    "numberofleasesrenewedorextended": 2,
    "rightofuseassets": 500000,
    "leaseliabilities": 132000,
    "expenserelatingtoleasesoflowvalueassetsforwhichrecognitionexemptionhasbeenused": 480000,
    "expenserelatingtoshorttermleasesforwhichrecognitionexemptionhasbeenused": 227000,
    "expenserelatingtovariableleasepaymentsnotincludedinmeasurementofleaseliabilities": 6000,
    "undiscountedoperatingleasepaymentstobereceived": 701000,
    "leaseeffectofdiscounting": -62000,
    "depreciationrightofuseassets": 251000,
    "gainslossesarisingfromsaleandleasebacktransactions": 272000,
    "undiscountedoperatingleasepaymentsextensionoptionsnotexpectedtobeexercised": 256000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 2770000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 135000,
    "keymanagementpersonnelcompensationsharebasedpayment": 4255000,
    "keymanagementpersonnelcompensation": 7160000,
    "increaseininterestrates": 0.005,
    "increaseininterestincomeoncashandcashequivalentsheldonvariableandshorttermfixedratedeposits": 169000,
    "percentageofincreaseinforeignexchangerate": 0.01,
    "increasedecreasethroughforeignexchangefinancialassetsliabilities": 283000,
    "prepaymentsandaccruedincomeandotherreceivables": 2891000,
    "tradeandotherpayablestotradesuppliers": 727000,
    "provision": 4146000,
    "provisionscharge": 4100000
  },
  {
    "date": "2021-12-31",
    "symbol": "NCNA",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "NCNA",
    "entityregistrantname": "NUCANA PLC",
    "entitycentralindexkey": 1709626,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated filer",
    "entitycommonstocksharesoutstanding": "null",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "American Depositary Shares, each representing one Ordinary Share, nominal value £0.04 per share",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityfilenumber": "001-38215",
    "entityincorporationstatecountrycode": "England and Wales",
    "contactpersonnelname": "Hugh S. Griffith",
    "entityaddressaddressline1": "NuCana plc",
    "entityaddressaddressline2": "3 Lochside Way",
    "entityaddresscityortown": "Edinburgh",
    "entityaddresscountry": "United Kingdom",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "localphonenumber": "357 1111",
    "cityareacode": 131,
    "entityaddresspostalzipcode": "EH12 9DT",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "documentregistrationstatement": "false",
    "documentshellcompanyreport": "false",
    "icfrauditorattestationflag": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 1438,
    "auditorlocation": "Edinburgh, Scotland",
    "researchanddevelopmentexpense": 36834000,
    "administrativeexpense": 8529000,
    "impairmentlossrecognisedinprofitorloss": 2809000,
    "gainslossesonexchangedifferencesontranslationbeforetax": 267000,
    "profitlossfromoperatingactivities": -47905000,
    "financeincome": 103000,
    "profitlossbeforetax": -47802000,
    "incometaxexpensecontinuingoperations": -7269000,
    "profitloss": -40533000,
    "basicanddilutedearninglosspershare": -0.78,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 5000,
    "othercomprehensiveincome": 5000,
    "comprehensiveincome": -40533000,
    "comprehensiveincomeattributabletoownersofparent": -40528000,
    "intangibleassetsotherthangoodwill": 65000,
    "propertyplantandequipment": 349000,
    "deferredtaxassets": 60000,
    "othernoncurrentassets": 2540000,
    "noncurrentassets": 5861000,
    "tradeandothercurrentreceivables": 4161000,
    "currenttaxassetscurrent": 4000,
    "cashandcashequivalents": 41371000,
    "currentassets": 71613000,
    "assets": 77474000,
    "sharecapitalandsharepremium": 143137000,
    "otherreserves": 72137000,
    "retainedearnings": -149726000,
    "equity": -149726000,
    "noncurrentprovisions": 46000,
    "noncurrentleaseliabilities": 164000,
    "noncurrentliabilities": 210000,
    "tradeandothercurrentpayablestotradesuppliers": 1829000,
    "currentprovisionsforemployeebenefits": 1000,
    "accrualsclassifiedascurrent": 915000,
    "currentleaseliabilities": 207000,
    "currentliabilities": 11716000,
    "liabilities": 11926000,
    "equityandliabilities": 77474000,
    "increasedecreasethroughsharebasedpaymenttransactions": 6664000,
    "increasedecreasethroughexerciseofoptions": 182000,
    "lapseofshareoptions": 197000,
    "adjustmentsforincometaxexpense": -7269000,
    "adjustmentsfordepreciationandamortisationexpense": 942000,
    "adjustmentsforimpairmentofintangibleassets": 2809000,
    "adjustmentsforfinanceincome": 103000,
    "interestexpenseonleaseliabilities": 18000,
    "adjustmentsforsharebasedpayments": 6664000,
    "adjustmentsforunrealisedforeignexchangelossesgains": -335000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -37807000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 473000,
    "adjustmentsforincreasedecreaseintradeaccountpayable": -428000,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": 4050000,
    "increasedecreaseinworkingcapital": 4095000,
    "cashflowsfromusedinoperations": -33712000,
    "incometaxespaidrefundclassifiedasoperatingactivities": -9888000,
    "cashflowsfromusedinoperatingactivities": -23824000,
    "interestreceivedclassifiedasinvestingactivities": 101000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 64000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 1001000,
    "purchaseofotherlongtermassetsclassifiedasinvestingactivities": 2597000,
    "cashflowsfromusedininvestingactivities": -3561000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 296000,
    "proceedsfromexerciseofoptions": 198000,
    "cashflowsfromusedinfinancingactivities": -98000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -27483000,
    "effectofexchangeratechangesoncashandcashequivalents": 391000,
    "nameofreportingentityorothermeansofidentification": "NuCana plc",
    "descriptionofnatureofentitysoperationsandprincipalactivities": "clinical-stage biopharmaceutical company developing a portfolio of new medicines to treat patients with cancer",
    "domicileofentity": "United Kingdom",
    "countryofincorporation": "England and Wales",
    "nameofsubsidiary": "NuCana Limited, NuCana, Inc. and NuCana BioMed Trustee Company Limited",
    "numberofsubsidiaries": 3,
    "accruedclinicaltrialexpenses": 7200000,
    "prepaymentsforclinicaltrialexpenses": 1500000,
    "accruedcontractedmanufacturingexpense": 100000,
    "prepaymentsforcontractedmanufacturingexpense": 100000,
    "numberofoperatingsegment": 1,
    "usefullivesoramortizationratesofintangibleassetsotherthangoodwill": "P5Y",
    "cashatbanksmaturityperiod": " less than three months",
    "incometaxcreditcashrebatepercentage": 0.3335,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P5Y",
    "depreciationmethodpropertyplantandequipment": "Straight-line",
    "amortisationmethodintangibleassetsotherthangoodwill": "Straight-line",
    "wagesandsalaries": 1407000,
    "socialsecuritycontributions": 136000,
    "postemploymentbenefitexpensedefinedbenefitplans": 40000,
    "expensefromsharebasedpaymenttransactionswithemployees": 6700000,
    "employeebenefitsexpense": 12832000,
    "averagenumberofemployees": 30,
    "directorsremunerationexpense": 850000,
    "directorsremunerationpensionandotherbenefitsexpense": 57000,
    "directorsremunerationexpenseincludingpensionandotherbenefitsexpense": 907000,
    "numberofdirectorsexercisedshareoptions": 3,
    "gainonexerciseofoption": 700000,
    "weightedaverageshares": 52041000,
    "amortisationexpense": 535000,
    "depreciationexpense": 407000,
    "researchcollaborationandlicenseagreementadditionalterm": "two years",
    "milestonepayments": 4500000,
    "estimatedfinancialeffectofcontingentliabilities": 400000,
    "currentlyprevailingpercentageofemployernationalinsurance": 0.138,
    "paymentofsecuritydeposittocoverlegalcosts": 3000000,
    "currenttaxexpenseincome": -7185000,
    "adjustmentsforcurrenttaxofpriorperiod": -69000,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": -7254000,
    "deferredtaxexpenseincome": -15000,
    "adjustmentsfordeferredtaxofpriorperiods": 4325000,
    "deferredtaxexpenseincomerecognisedinprofitorloss": -15000,
    "accountingprofit": -47802000,
    "taxexpenseincomeatapplicabletaxrate": -9082000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 4757000,
    "taxeffectofdeductionforresearchanddevelopment": -9415000,
    "taxeffectoftaxlosses": 9415000,
    "taxeffectofresearchanddevelopmenttaxcreditforeign": -15000,
    "taxeffectofresearchanddevelopmenttaxcreditcurrentyear": -7185000,
    "taxeffectofresearchanddevelopmenttaxcreditprioryears": -69000,
    "applicabletaxrate": 0.19,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 74400000,
    "temporarydifferencesforsharebasedcompensationarrangements": 4099999.9999999995,
    "cumulativecarryforwardtaxlosses": 70300000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 1001000,
    "amortisationintangibleassetsotherthangoodwill": 535000,
    "impairmentlossrecognisedinprofitorlossintangibleassetsotherthangoodwill": 2800000,
    "numberofclinicaltrial": 3,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 65000,
    "revaluationincreasedecreasepropertyplantandequipment": 4000,
    "depreciationpropertyplantandequipment": 407000,
    "disposalspropertyplantandequipment": -6000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": 2000,
    "securitydeposittocoverlegalcosts": 3000000,
    "prepaymentsmanufacturingandclinical": 1598000,
    "prepaymentsother": 1551000,
    "accruedincomeotherthancontractassets": 5000,
    "valueaddedtaxreceivables": 998000,
    "otherreceivables": 9000,
    "tradeandotherreceivables": 4161000,
    "issuedcapital": 2087000,
    "sharepremium": 141050000,
    "numberofsharesissued": 52180000,
    "parvaluepershare": 0.04,
    "numberofsharesissuedandfullypaid": 52180000,
    "numberofsharesissuedonexerciseofoptions": 1005000,
    "reserveofdiscretionaryparticipationfeatures": -339000,
    "reserveofexchangedifferencesontranslation": -17000,
    "capitalreserve": 42466000,
    "shareoptionreserve": 30027000,
    "reserveofsharebasedpayment": 6974000,
    "reserveofshareoptionsexercised": -1222000,
    "reserveofshareoptionsforfeiture": -310000,
    "lapseofshareoptionsreserve": -197000,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 500000,
    "numberofequitysettledsharebasedpaymentplans": 6,
    "descriptionofoptionlifeshareoptionsgranted": 4.5,
    "shareoptionsgrantedvestingperiod": "four years",
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": 7.59,
    "termofshareoptionsexercised": 2,
    "numberofoutstandingshareoptions": "null",
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 165000,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 193949,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 42750,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": "null",
    "numberofshareoptionsvestedandexercisableinsharebasedpaymentarrangement": "null",
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 3.32,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 1.91,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 5.26,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 11.21,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.2,
    "weightedaverageexercisepriceofshareoptionsvestedandexercisableinsharebasedpaymentarrangement": 3.51,
    "weightedaverageexercisepriceofshareoptionsinsharebasedpaymentarrangementexercisedduringperiodatdateofexercise2019": 3.77,
    "exercisepriceofoutstandingshareoptions2019": 18.05,
    "descriptionofvestingdateofshareoptionsgranted": "Dec 15, 2025",
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.818,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0048,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 1050,
    "weightedaveragesharepriceshareoptionsgranted2019": 1.72,
    "exercisepriceshareoptionsgranted2019": 1.72,
    "descriptionoflapsedateofshareoptionsgranted": "Dec 15, 2031",
    "informationaboutnatureoflesseesleasingactivities": "lease terms of between two and five years",
    "cashoutflowforleases": 300000,
    "informationaboutlesseesexposurearisingfromvariableleasepayments": "The Company has one lease contract with variable payments where the lease costs after the first year of the lease are increased based upon a consumer price index.",
    "numberofleasecontractswithvariableleasepayments": 1,
    "informationaboutlesseesexposurearisingfromextensionoptionsandterminationoptions": "The Company has a number of lease contracts that include extension and termination options. These options are negotiated by management to provide flexibility in managing the leased asset portfolio and align it with the Company’s business needs. None of the termination options have been exercised or are expected to be exercised.",
    "leaseliabilities": 55000,
    "expenserelatingtoleasesoflowvalueassetsforwhichrecognitionexemptionhasbeenused": 4000,
    "expenserelatingtoshorttermleasesforwhichrecognitionexemptionhasbeenused": 296000,
    "undiscountedoperatingleasepaymentstobereceived": 385000,
    "leaseeffectofdiscounting": -14000,
    "depreciationrightofuseassets": 266000,
    "gainslossesarisingfromsaleandleasebacktransactions": 284000,
    "undiscountedoperatingleasepaymentsextensionoptionsnotexpectedtobeexercised": 978000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 2165000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 104000,
    "keymanagementpersonnelcompensationsharebasedpayment": 5637000,
    "keymanagementpersonnelcompensation": 7906000,
    "increaseininterestrates": 0.005,
    "increaseininterestincomeoncashandcashequivalentsheldonvariableandshorttermfixedratedeposits": 278000,
    "percentageofincreaseinforeignexchangerate": 0.01,
    "increasedecreasethroughforeignexchangefinancialassetsliabilities": -417000,
    "prepaymentsandaccruedincomeandotherreceivables": 2063000,
    "tradeandotherpayablestotradesuppliers": 773000
  },
  {
    "date": "2020-12-31",
    "symbol": "NCNA",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "NCNA",
    "entityregistrantname": "NUCANA PLC",
    "entitycentralindexkey": 1709626,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated Filer",
    "entitycommonstocksharesoutstanding": 51174545,
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "American Depositary Shares, each representing one Ordinary Share, nominal value £0.04 per share",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-38215",
    "entityincorporationstatecountrycode": "X0",
    "contactpersonnelname": "Hugh S. Griffith",
    "entityaddressaddressline1": "NuCana plc",
    "entityaddressaddressline2": "3 Lochside Way",
    "entityaddresscityortown": "Edinburgh",
    "entityaddresscountry": "GB",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "localphonenumber": 3571111,
    "cityareacode": 131,
    "entityaddresspostalzipcode": "EH12 9DT",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "documentregistrationstatement": "false",
    "documentshellcompanyreport": "false",
    "icfrauditorattestationflag": "false",
    "researchanddevelopmentexpense": 25899000,
    "administrativeexpense": 7050000,
    "gainslossesonexchangedifferencesontranslationbeforetax": -3472000,
    "profitlossfromoperatingactivities": -36421000,
    "financeincome": 246000,
    "profitlossbeforetax": -36175000,
    "incometaxexpensecontinuingoperations": -5493000,
    "profitloss": -30682000,
    "basicanddilutedearningslosspershare": -0.81,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -12000,
    "othercomprehensiveincome": -12000,
    "comprehensiveincome": -30682000,
    "comprehensiveincomeattributabletoownersofparent": -30694000,
    "intangibleassetsotherthangoodwill": 157000,
    "propertyplantandequipment": 450000,
    "deferredtaxassets": 44000,
    "noncurrentassets": 5986000,
    "tradeandothercurrentreceivables": 4628000,
    "currenttaxassetscurrent": 4000,
    "cashandcashequivalents": 70419000,
    "currentassets": 101806000,
    "assets": 107792000,
    "sharecapitalandsharepremium": 142937000,
    "otherreserves": 66887000,
    "retainedearnings": -110594000,
    "equity": -110594000,
    "noncurrentprovisions": 46000,
    "noncurrentleaseliabilities": 367000,
    "noncurrentliabilities": 413000,
    "tradeandothercurrentpayablestotradesuppliers": 2257000,
    "currentprovisionsforemployeebenefits": 1000,
    "accrualsclassifiedascurrent": 926000,
    "currentleaseliabilities": 278000,
    "currentliabilities": 8149000,
    "liabilities": 8562000,
    "equityandliabilities": 107792000,
    "increasedecreasethroughsharebasedpaymenttransactions": 4305000,
    "increasedecreasethroughexerciseofoptions": 15000,
    "lapseofshareoptions": 75000,
    "issueofequity": 66581000,
    "shareissuerelatedcost": 4499000,
    "adjustmentsforincometaxexpense": -5493000,
    "adjustmentsfordepreciationandamortisationexpense": 890000,
    "adjustmentsforfinanceincome": 246000,
    "interestexpenseonleaseliabilities": 26000,
    "adjustmentsforsharebasedpayments": 4305000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 3481000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -27719000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": -9000,
    "adjustmentsforincreasedecreaseintradeaccountpayable": -155000,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": 2112000,
    "increasedecreaseinworkingcapital": 1948000,
    "cashflowsfromusedinoperations": -25771000,
    "incometaxespaidrefundclassifiedasoperatingactivities": -4152000,
    "cashflowsfromusedinoperatingactivities": -21619000,
    "interestreceivedclassifiedasoperatingactivities": 319000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 361000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 1271000,
    "cashflowsfromusedininvestingactivities": -1313000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 297000,
    "proceedsfromexerciseofoptions": 15000,
    "proceedsfromissuingshares": 66581000,
    "paymentsforshareissuecosts": 4499000,
    "cashflowsfromusedinfinancingactivities": 61800000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 38868000,
    "effectofexchangeratechangesoncashandcashequivalents": -3474000,
    "nameofreportingentityorothermeansofidentification": "NuCana plc",
    "descriptionofnatureofentitysoperationsandprincipalactivities": "clinical-stage biopharmaceutical company developing a portfolio of new medicines to treat patients with cancer",
    "domicileofentity": "United Kingdom",
    "countryofincorporation": "England and Wales",
    "nameofsubsidiary": "NuCana, Inc. and NuCana BioMed Trustee Company Limited",
    "numberofsubsidiaries": 2,
    "accruedclinicaltrialexpenses": 3500000,
    "prepaymentsforclinicaltrialexpenses": 2200000,
    "accruedcontractedmanufacturingexpense": 100000,
    "numberofoperatingsegment": 1,
    "usefullivesoramortizationratesofintangibleassetsotherthangoodwill": "P5Y",
    "cashatbanksmaturityperiod": "Less than three months",
    "incometaxcreditcashrebatepercentage": 0.3335,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P5Y",
    "depreciationmethodpropertyplantandequipment": "Straight-line",
    "amortisationmethodintangibleassetsotherthangoodwill": "Straight-line",
    "wagesandsalaries": 1387000,
    "socialsecuritycontributions": 135000,
    "postemploymentbenefitexpensedefinedbenefitplans": 47000,
    "expensefromsharebasedpaymenttransactionswithemployees": 4300000,
    "employeebenefitsexpense": 9985000,
    "averagenumberofemployees": 30,
    "directorsremunerationexpense": 861000,
    "directorsremunerationpensionandotherbenefitsexpense": 59000,
    "directorsremunerationexpenseincludingpensionandotherbenefitsexpense": 920000,
    "weightedaverageshares": 37882000,
    "amortisationexpense": 478000,
    "depreciationexpense": 412000,
    "researchcollaborationandlicenseagreementadditionalterm": "P2Y",
    "paymentsfordevelopmentprojectexpenditure": 175052,
    "milestonepayments": 4500000,
    "estimatedfinancialeffectofcontingentliabilities": 800000,
    "currentlyprevailingpercentageofemployernationalinsurance": 0.138,
    "currenttaxexpenseincome": -5516000,
    "adjustmentsforcurrenttaxofpriorperiod": 22000,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": -5494000,
    "adjustmentsfordeferredtaxofpriorperiods": 2901000,
    "deferredtaxexpenseincomerecognisedinprofitorloss": 1000,
    "accountingprofit": -36175000,
    "taxexpenseincomeatapplicabletaxrate": -6873000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 3972000,
    "taxeffectofdeductionforresearchanddevelopment": -7228000,
    "taxeffectoftaxlosses": 7228000,
    "taxeffectofdeferredtaxprioryearadjustment": 1000,
    "taxeffectofresearchanddevelopmenttaxcreditcurrentyear": -5516000,
    "taxeffectofresearchanddevelopmenttaxcreditprioryears": 22000,
    "applicabletaxrate": 0.19,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 57500000,
    "temporarydifferencesforsharebasedcompensationarrangements": 9900000,
    "cumulativecarryforwardtaxlosses": 47600000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 1271000,
    "amortisationintangibleassetsotherthangoodwill": 478000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 381000,
    "revaluationincreasedecreasepropertyplantandequipment": 115000,
    "depreciationpropertyplantandequipment": 412000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": -6000,
    "prepaymentsmanufacturingandclinical": 2177000,
    "prepaymentsother": 1625000,
    "accruedincome": 4000,
    "valueaddedtaxreceivables": 813000,
    "otherreceivables": 9000,
    "tradeandotherreceivables": 4628000,
    "issuedcapital": 2047000,
    "sharepremium": 140890000,
    "numberofsharesissued": 51175000,
    "parvaluepershare": 0.04,
    "numberofsharesissuedandfullypaid": 51175000,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 32500,
    "issueofsharecapital": 61335000,
    "increasedecreaseinnumberofordinarysharesissued": 18663000,
    "reserveofdiscretionaryparticipationfeatures": -339000,
    "reserveofexchangedifferencesontranslation": -22000,
    "capitalreserve": 42466000,
    "shareoptionreserve": 24782000,
    "reserveofsharebasedpayment": 4823000,
    "reserveofshareoptionsexercised": -68000,
    "reserveofshareoptionsforfeiture": -518000,
    "lapseofshareoptionsreserve": -75000,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 500000,
    "numberofequitysettledsharebasedpaymentplans": 6,
    "descriptionofoptionlifeshareoptionsgranted": 4.5,
    "shareoptionsgrantedvestingperiod": "P4Y",
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P5Y9M7D",
    "termofshareoptionsexercised": "P2Y",
    "numberofoutstandingshareoptions": 7724791,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 80000,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 192750,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 14438,
    "numberofshareoptionsvestedandexercisableinsharebasedpaymentarrangement": 4176281,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 3.78,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 4.03,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 10.89,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 7.42,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.45,
    "weightedaverageexercisepriceofshareoptionsvestedandexercisableinsharebasedpaymentarrangement": 2.07,
    "weightedaverageexercisepriceofshareoptionsinsharebasedpaymentarrangementexercisedduringperiodatdateofexercise2019": 4.63,
    "exercisepriceofoutstandingshareoptions2019": 18.05,
    "descriptionofvestingdateofshareoptionsgranted": "2024-12-09",
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.8126,
    "descriptionofriskfreeinterestrateshareoptionsgranted": -0.0003,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 2.1,
    "weightedaveragesharepriceshareoptionsgranted2019": 3.48,
    "exercisepriceshareoptionsgranted2019": 3.48,
    "descriptionoflapsedateofshareoptionsgranted": "2030-12-09",
    "informationaboutnatureoflesseesleasingactivities": "lease terms of between two and five years",
    "cashoutflowforleases": 300000,
    "expenserelatingtoleasesoflowvalueassetsforwhichrecognitionexemptionhasbeenused": 115000,
    "informationaboutlesseesexposurearisingfromvariableleasepayments": "The Company has one lease contract with variable payments where the lease costs after the first year of the lease are increased based upon a consumer price index.",
    "numberofleasecontractswithvariableleasepayments": 1,
    "informationaboutlesseesexposurearisingfromextensionoptionsandterminationoptions": "The Company has a number of lease contracts that include extension and termination options. These options are negotiated by management to provide flexibility in managing the leased asset portfolio and align it with the Company’s business needs. None of the termination options have been exercised or are expected to be exercised.",
    "leaseliabilities": 105000,
    "expenserelatingtoshorttermleasesforwhichrecognitionexemptionhasbeenused": 297000,
    "expenserelatingtovariableleasepaymentsnotincludedinmeasurementofleaseliabilities": 5000,
    "undiscountedoperatingleasepaymentstobereceived": 677000,
    "leaseeffectofdiscounting": -32000,
    "depreciationrightofuseassets": 268000,
    "gainslossesarisingfromsaleandleasebacktransactions": 294000,
    "undiscountedoperatingleasepaymentsextensionoptionsnotexpectedtobeexercised": 978000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 1658000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 79000,
    "keymanagementpersonnelcompensationsharebasedpayment": 3377000,
    "keymanagementpersonnelcompensation": 5114000,
    "increaseininterestrates": 0.005,
    "increaseininterestincomeoncashandcashequivalentsheldonvariableandshorttermfixedratedeposits": 269511,
    "percentageofincreaseinforeignexchangerate": 0.01,
    "increasedecreasethroughforeignexchangefinancialassetsliabilities": -710592,
    "prepaymentsandaccruedincomeandotherreceivables": 2079000,
    "tradeandotherpayablestotradesuppliers": 409000
  },
  {
    "date": "2019-12-31",
    "symbol": "NCNA",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "NCNA",
    "entityregistrantname": "NUCANA PLC",
    "entitycentralindexkey": 1709626,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitycommonstocksharesoutstanding": 32478645,
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "American Depositary Shares, each representing one Ordinary Share, nominal value £0.04 per share",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-38215",
    "entityincorporationstatecountrycode": "X0",
    "contactpersonnelname": "Hugh S. Griffith",
    "entityaddressaddressline1": "NuCana plc",
    "entityaddressaddressline2": "3 Lochside Way",
    "entityaddresscityortown": "Edinburgh",
    "entityaddresscountry": "GB",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "localphonenumber": 3571111,
    "cityareacode": 131,
    "entityaddresspostalzipcode": "EH12 9DT",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "documentregistrationstatement": "false",
    "documentshellcompanyreport": "false",
    "researchanddevelopmentexpense": 19728000,
    "administrativeexpense": 5953000,
    "gainslossesonexchangedifferencesontranslationbeforetax": -1019000,
    "profitlossfromoperatingactivities": -26700000,
    "financeincome": 1049000,
    "profitlossbeforetax": -25651000,
    "incometaxexpensecontinuingoperations": -4239000,
    "profitloss": -21412000,
    "basicanddilutedearningslosspershare": -0.66,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -11000,
    "othercomprehensiveincome": -11000,
    "comprehensiveincome": -21412000,
    "comprehensiveincomeattributabletoownersofparent": -21423000,
    "intangibleassetsotherthangoodwill": 243000,
    "propertyplantandequipment": 242000,
    "deferredtaxassets": 46000,
    "noncurrentassets": 5115000,
    "tradeandothercurrentreceivables": 4710000,
    "currenttaxassetscurrent": 4000,
    "cashandcashequivalents": 28980000,
    "currentassets": 65153000,
    "assets": 70268000,
    "sharecapitalandsharepremium": 80840000,
    "otherreserves": 62737000,
    "retainedearnings": -80055000,
    "equity": -80055000,
    "noncurrentprovisions": 26000,
    "noncurrentleaseliabilities": 538000,
    "noncurrentliabilities": 564000,
    "tradeandothercurrentpayablestotradesuppliers": 2412000,
    "currentprovisionsforemployeebenefits": 18000,
    "accrualsclassifiedascurrent": 989000,
    "currentleaseliabilities": 268000,
    "currentliabilities": 6182000,
    "liabilities": 6746000,
    "equityandliabilities": 70268000,
    "increasedecreasethroughsharebasedpaymenttransactions": 3226000,
    "increasedecreasethroughexerciseofoptions": 125000,
    "lapseofshareoptions": 38000,
    "adjustmentsforincometaxexpense": -4239000,
    "adjustmentsfordepreciationandamortisationexpense": 718000,
    "adjustmentsforfinanceincome": 1049000,
    "adjustmentsforsharebasedpayments": 3226000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 1006000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -21750000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 2452000,
    "adjustmentsforincreasedecreaseintradeaccountpayable": 43000,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": -393000,
    "increasedecreaseinworkingcapital": -2102000,
    "cashflowsfromusedinoperations": -23852000,
    "incometaxespaidrefundclassifiedasoperatingactivities": -19000,
    "cashflowsfromusedinoperatingactivities": -23833000,
    "interestreceivedclassifiedasoperatingactivities": 1116000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 46000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 1215000,
    "cashflowsfromusedininvestingactivities": -145000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 197000,
    "proceedsfromleaseincentivesreceived": 25000,
    "proceedsfromexerciseofoptions": 125000,
    "cashflowsfromusedinfinancingactivities": -47000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -24025000,
    "effectofexchangeratechangesoncashandcashequivalents": -985000,
    "nameofreportingentityorothermeansofidentification": "NuCana plc",
    "descriptionofnatureofentitysoperationsandprincipalactivities": "clinical-stage biopharmaceutical company developing a portfolio of new medicines to treat cancer",
    "domicileofentity": "United Kingdom",
    "countryofincorporation": "England and Wales",
    "nameofsubsidiary": "NuCana, Inc. and NuCana BioMed Trustee Company Limited",
    "numberofsubsidiaries": 2,
    "accruedclinicaltrialexpenses": 1700000,
    "accruedcontractedmanufacturingexpense": 200000,
    "numberofoperatingsegment": 1,
    "usefullivesoramortizationratesofintangibleassetsotherthangoodwill": "P5Y",
    "cashatbanksmaturityperiod": "Less than three months",
    "incometaxcreditcashrebatepercentage": 0.3335,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P5Y",
    "depreciationmethodpropertyplantandequipment": "Straight-line",
    "amortisationmethodintangibleassetsotherthangoodwill": "Straight-line",
    "undiscountedoperatingleasepaymentstobereceived": 860000,
    "leaseliabilities": 52000,
    "wagesandsalaries": 1190000,
    "socialsecuritycontributions": 115000,
    "postemploymentbenefitexpensedefinedbenefitplans": 37000,
    "expensefromsharebasedpaymenttransactionswithemployees": 3200000,
    "employeebenefitsexpense": 8407000,
    "averagenumberofemployees": 28,
    "directorsremunerationexpense": 780000,
    "directorsremunerationpensionandotherbenefitsexpense": 48000,
    "directorsremunerationexpenseincludingpensionandotherbenefitsexpense": 828000,
    "numberofdirectorsexercisedshareoptions": 1,
    "gainonexerciseofoption": 1400000,
    "weightedaverageshares": 32327000,
    "amortisationexpense": 377000,
    "depreciationexpense": 341000,
    "researchcollaborationandlicenseagreementadditionalterm": "P2Y",
    "paymentsfordevelopmentprojectexpenditure": 292607,
    "milestonepayments": 4500000,
    "estimatedfinancialeffectofcontingentliabilities": 1300000,
    "currentlyprevailingpercentageofemployernationalinsurance": 0.138,
    "currenttaxexpenseincome": 1000,
    "adjustmentsforcurrenttaxofpriorperiod": 86000,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": -4238000,
    "deferredtaxexpenseincome": -1000,
    "adjustmentsfordeferredtaxofpriorperiods": 1962000,
    "deferredtaxexpenseincomerecognisedinprofitorloss": -1000,
    "accountingprofit": -25651000,
    "taxexpenseincomeatapplicabletaxrate": -4874000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 2912000,
    "taxeffectofdeductionforresearchanddevelopment": -5667000,
    "taxeffectoftaxlosses": 5667000,
    "taxeffectofforeigntaxratescurrentyear": 1000,
    "taxeffectofresearchanddevelopmenttaxcreditforeign": -1000,
    "taxeffectofresearchanddevelopmenttaxcreditcurrentyear": -4325000,
    "taxeffectofresearchanddevelopmenttaxcreditprioryears": 86000,
    "applicabletaxrate": 0.19,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 46400000,
    "temporarydifferencesforsharebasedcompensationarrangements": 14200000,
    "cumulativecarryforwardtaxlosses": 32200000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 1215000,
    "amortisationintangibleassetsotherthangoodwill": 377000,
    "recognizedonadoptionofaccountingpronouncements": 455000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 569000,
    "revaluationincreasedecreasepropertyplantandequipment": 2000,
    "depreciationpropertyplantandequipment": 341000,
    "disposalspropertyplantandequipment": 1000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": -2000,
    "prepaymentsmanufacturingandclinical": 2630000,
    "prepaymentsother": 1489000,
    "accruedincome": 76000,
    "valueaddedtaxreceivables": 475000,
    "otherreceivables": 40000,
    "tradeandotherreceivables": 4710000,
    "issuedcapital": 1299000,
    "sharepremium": 79541000,
    "numberofsharesissued": 32479000,
    "parvaluepershare": 0.04,
    "numberofsharesissuedandfullypaid": 32479000,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 252187,
    "reserveofdiscretionaryparticipationfeatures": -339000,
    "reserveofexchangedifferencesontranslation": -10000,
    "capitalreserve": 42466000,
    "shareoptionreserve": 20620000,
    "reserveofsharebasedpayment": 3289000,
    "reserveofshareoptionsexercised": -132000,
    "reserveofshareoptionsforfeiture": -63000,
    "lapseofshareoptionsreserve": -38000,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 500000,
    "numberofequitysettledsharebasedpaymentplans": 3,
    "descriptionofoptionlifeshareoptionsgranted": 4.5,
    "shareoptionsgrantedvestingperiod": "P4Y",
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P4Y7M17D",
    "termofshareoptionsexercised": "P2Y",
    "numberofoutstandingshareoptions": 5298840,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 114000,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 48625,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 8750,
    "numberofshareoptionsvestedandexercisableinsharebasedpaymentarrangement": 3811736,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 3.91,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 10.82,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 10.42,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 3.9,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.5,
    "weightedaverageexercisepriceofshareoptionsvestedandexercisableinsharebasedpaymentarrangement": 1.15,
    "weightedaverageexercisepriceofshareoptionsinsharebasedpaymentarrangementexercisedduringperiodatdateofexercise2019": 7.65,
    "exercisepriceofoutstandingshareoptions2019": 18.05,
    "descriptionofvestingdateofshareoptionsgranted": "2023-09-11",
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.7014,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0044,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 4.22,
    "weightedaveragesharepriceshareoptionsgranted2019": 7.79,
    "exercisepriceshareoptionsgranted2019": 7.79,
    "descriptionoflapsedateofshareoptionsgranted": "2029-09-11",
    "informationaboutnatureoflesseesleasingactivities": "lease terms of between two and five years",
    "cashoutflowforleases": 200000,
    "noncashadditionstorightofuseassetsandleaseliabilities": 500000,
    "informationaboutlesseesexposurearisingfromvariableleasepayments": "The Company has one lease contract with variable payments where the lease costs after the first year of the lease are increased based upon a consumer price index.",
    "numberofleasecontractswithvariableleasepayments": 1,
    "informationaboutlesseesexposurearisingfromextensionoptionsandterminationoptions": "The Company has a number of lease contracts that include extension and termination options. These options are negotiated by management to provide flexibility in managing the leased-asset portfolio and align it with the Company’s business needs. None of the termination options are expected to be exercised.",
    "additionstorightofuseassets": 548000,
    "expenserelatingtoleasesoflowvalueassetsforwhichrecognitionexemptionhasbeenused": 2000,
    "interestexpenseonleaseliabilities": 21000,
    "expenserelatingtoshorttermleasesforwhichrecognitionexemptionhasbeenused": 197000,
    "expenserelatingtovariableleasepaymentsnotincludedinmeasurementofleaseliabilities": 2000,
    "leaseeffectofdiscounting": -54000,
    "depreciationrightofuseassets": 193000,
    "gainslossesarisingfromsaleandleasebacktransactions": 214000,
    "undiscountedoperatingleasepaymentsextensionoptionsnotexpectedtobeexercised": 978000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 1686000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 69000,
    "keymanagementpersonnelcompensationsharebasedpayment": 1976000,
    "keymanagementpersonnelcompensation": 3731000,
    "increaseininterestrates": 0.005,
    "increaseininterestincomeoncashandcashequivalents": 244674,
    "percentageofincreaseinforeignexchangerate": 0.01,
    "increasedecreasethroughforeignexchangefinancialassetsliabilities": -295498,
    "prepaymentsandaccruedincomeandotherreceivables": 2174000,
    "tradeandotherpayablestotradesuppliers": 549000
  }
]